<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H08CEA67A2386480CB291FE0A54E5A417" public-private="public" key="H" bill-type="olc">
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 5150 IH: To direct the Secretary of Defense to submit to Congress a report evaluating beneficiary access to TRICARE network pharmacies.</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-08-04</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code>
<congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session>
<legis-num display="yes">H. R. 5150</legis-num>
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
<action display="yes">
<action-date date="20230804">August 4, 2023</action-date>
<action-desc><sponsor name-id="N000191">Mr. Neguse</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HAS00">Committee on Armed Services</committee-name></action-desc>
</action>
<legis-type>A BILL</legis-type>
<official-title display="yes">To direct the Secretary of Defense to submit to Congress a report evaluating beneficiary access to TRICARE network pharmacies.</official-title>
</form>
<legis-body id="HFCE5E336B4A84ADA932A75672861FEA9" style="OLC">
<section id="H90C2A7E2FBDE453FBA8F616433B407C8" section-type="section-one"><enum>1.</enum><header>Report on access of TRICARE beneficiaries to network retail pharmacies</header>
<subsection id="H4F60E26F6A374B528C5842E226508940"><enum>(a)</enum><header>Report required</header><text>Not later than 180 days after the date of the enactment of this Act, the Secretary of Defense shall submit to Congress a report evaluating beneficiary access to TRICARE network pharmacies under the TPharm5 contract and changes in beneficiary access versus the TPharm4 contract.</text></subsection> <subsection id="HC67C08A6B3B447B498685ED2E7B1112F"><enum>(b)</enum><header>Elements</header><text>The report required under subsection (a) shall include the following:</text>
<paragraph id="H14971912644A4B108FDAC336EB3AAE21"><enum>(1)</enum><text>An analysis of pharmacy access in rural areas under such contracts, including:</text> <subparagraph id="H058CADDF59714666B6AA5061C5BF4897"><enum>(A)</enum><text>The number of TRICARE beneficiaries and number of TRICARE network retail pharmacies located in rural areas.</text></subparagraph>
<subparagraph id="HD031D4905B1243EDA272413B63824121"><enum>(B)</enum><text>The average drive time to the nearest TRICARE network retail pharmacy for a beneficiary residing in rural areas.</text></subparagraph> <subparagraph id="H73978AE77BE24EA4BBFF187211B77D10"><enum>(C)</enum><text display-inline="yes-display-inline">The number of beneficiaries who live farther than a 15-minute drive to a TRICARE retail network pharmacy.</text></subparagraph>
<subparagraph id="H75FAC8CA621047CEB1C807AE3D8583AC"><enum>(D)</enum><text>An assessment of medication compliance rates for beneficiaries residing in rural areas for the three years prior to October 24, 2022, compared to the period-to-date following October 24, 2022.</text></subparagraph></paragraph> <paragraph id="H8E3736B5C50540DE9CBBC94741E284C6"><enum>(2)</enum><text>An analysis of TRICARE retail pharmacy network capabilities under such contracts, including the number of network pharmacies offering—</text>
<subparagraph id="HDDCE977008CC47DBBC2A690BB630BC52"><enum>(A)</enum><text>long-term care services;</text></subparagraph> <subparagraph id="HD8EE2E29604E4964ADF7424B63B40684"><enum>(B)</enum><text>prescription drug compounding services; and</text></subparagraph>
<subparagraph id="H20C33A82A6DC4FBDBDB40446BA0CFF0E"><enum>(C)</enum><text>home infusion therapy services.</text></subparagraph></paragraph> <paragraph id="HB7B19DC7624A4224B3CE3F602BF32FFE"><enum>(3)</enum><text>An analysis of affected beneficiaries and their use of the TRICARE Pharmacy program under TPharm4 and TPharm5, including:</text>
<subparagraph id="HA8E397DD890B421CADBC82DAAF14B1C4"><enum>(A)</enum><text>Data on affected beneficiaries’ use of MTF pharmacies, TRICARE mail order program, Accredo, departed retail pharmacies, network retail pharmacies.</text></subparagraph> <subparagraph id="H33E34366875B4F039927B40704CEB202"><enum>(B)</enum><text display-inline="yes-display-inline">An assessment of medication compliance rates for affected beneficiaries for the three years prior to October 24, 2022, compared to the period-to-date following October 24, 2022.</text></subparagraph>
<subparagraph id="H094E6308A0C84A56AFCE61F52162A407"><enum>(C)</enum><text display-inline="yes-display-inline">Data on affected beneficiaries’ use of pharmacies that offer long-term care services, compound pharmacies, home infusion therapy.</text></subparagraph> <subparagraph id="HF545A021CCEF44B6A821187071266411"><enum>(D)</enum><text display-inline="yes-display-inline">The number of affected beneficiaries and number of total TRICARE beneficiaries by age group: under age 18, 18–24, 25–44, 45–64, 65–79, 80 and older.</text></subparagraph></paragraph>
<paragraph id="H86581B83592140408EF03BD2C7784722"><enum>(4)</enum><text>An analysis on the effect on long-term care residents under TPharm4 and TPharm5, including:</text> <subparagraph id="HD31580ABD6034024B1B98B28BF7B59E3"><enum>(A)</enum><text>The number of beneficiaries who filled at least one prescription at a pharmacy that provides long-term care services.</text></subparagraph>
<subparagraph id="H8F94D40762B348D29FE6F40AC6690F14"><enum>(B)</enum><text>The number of beneficiaries who filled prescriptions at a single long-term care pharmacy only with no prescriptions filled via mail order, MTF pharmacy, or another retail pharmacy.</text></subparagraph></paragraph> <paragraph id="H8343F2A0EA68463F8F335CF3897C6DC5"><enum>(5)</enum><text display-inline="yes-display-inline">An analysis of non-network pharmacy use by TRICARE beneficiaries under TPharm4 and TPharm5, disaggregated by rural beneficiaries, non-rural beneficiaries, affected beneficiaries, rural affected beneficiaries, and non-rural affected beneficiaries:</text>
<subparagraph id="H83A2EF5A5ECA4439AC76347522772895" display-inline="no-display-inline"><enum>(A)</enum><text>The number of beneficiaries who used a non-network pharmacy.</text></subparagraph> <subparagraph id="H6B097038F11748D9A0707013FF34A95C"><enum>(B)</enum><text>The number of non-network claims submitted.</text></subparagraph>
<subparagraph id="HA84CA2FC0B0C434AB4D003A457DA675B"><enum>(C)</enum><text>For all non-network claims submitted—</text> <clause id="H2D4771CA6DE24DDCBA6917ECB6B4ECB2"><enum>(i)</enum><text>the average TRICARE allowed amount per prescription;</text></clause>
<clause id="HA744FA0D1ECD4DFE97EB16472285BA8D"><enum>(ii)</enum><text>the average TRICARE amount paid per prescription; and</text></clause> <clause id="H4F3DBAC2E47E46339885BEBF45D5BC43"><enum>(iii)</enum><text>the average beneficiary out-of-pocket cost per prescription.</text></clause></subparagraph></paragraph></subsection>
<subsection id="H7A9F278FD7C14617B4EB842FD6D51089"><enum>(c)</enum><header>Definitions</header><text>In this section:</text> <paragraph id="H2045D5F151BB479899DEB17CF7BE4B42"><enum>(1)</enum><text>The term <quote>affected beneficiary</quote> means a beneficiary who filled at least one prescription in the year preceding October 24, 2022, at a departed pharmacy.</text></paragraph>
<paragraph id="HEA2DF4138F2D43E7AFA39E76FC25A63A"><enum>(2)</enum><text>The term <quote>beneficiary</quote> has the meaning given that term in section 1074g(i) of title 10, United States Code.</text></paragraph> <paragraph id="HFB8AE4FF1D0A4DA6999020010A291931"><enum>(3)</enum><text>The term <quote>departed retail pharmacy</quote> means a retail pharmacy that participated in the TRICARE network in September 2022 but left the network with the transition to the TPharm5 contract.</text></paragraph>
<paragraph id="H0EDDC60F69904AF7812FBD81E03E2AAA"><enum>(4)</enum><text display-inline="yes-display-inline">The term <quote>network pharmacy</quote> means a retail pharmacy described in section 1074g(a)(2)(E)(ii) of title 10, United States Code.</text></paragraph> <paragraph id="HBE35A8FA0E17488F95DBE5CEAE3744A7"><enum>(5)</enum><text>The term <quote>rural</quote>—</text>
<subparagraph id="HE1F19E1885074FD5A589C5318668A3E9"><enum>(A)</enum><text display-inline="yes-display-inline">with regards to a location, has the meaning given such term in section 343(a) of the Consolidated Farm and Rural Development Act (<external-xref legal-doc="usc" parsable-cite="usc/7/1991">7 U.S.C. 1991(a)</external-xref>); and</text></subparagraph> <subparagraph id="H1549621132F74643A8B979893E27815D"><enum>(B)</enum><text>with regards to a beneficiary, has the meaning used by the Secretary of Defense in the administration of section 1074g of title 10, United States Code.</text></subparagraph></paragraph>
<paragraph id="HEA7036F51CFF40909CA8B02A698EC92C"><enum>(6)</enum><text>The term <quote>TPharm4</quote> means the period covered by the 4th Generation pharmacy contract under TRICARE prior to October 24, 2022, when the retail network reduction went into effect.</text></paragraph> <paragraph id="H8E351FD530CC4EC98226F55AE78EC961"><enum>(7)</enum><text>The term <quote>TPharm5</quote> means the period covered by the 5th Generation pharmacy contract under TRICARE to date.</text></paragraph></subsection></section>
</legis-body>
</bill> 


